NSAIDS AND ALZHEIMER’S
ANCHOR LEAD: TAKING CERTAIN ANTI-INFLAMMATORY MEDICINES DOESN’T LOOK TO REDUCE THE RISK OF ALZHEIMER’S DISEASE, ELIZABETH TRACEY REPORTS
Use of the nonsteroidal anti-inflammatory medications naproxen and celecoxib does not appear to reduce one’s risk of developing Alzheimer’s disease, a multicenter study shows. Constantine Lyketsos, one of the study investigators and chair of psychiatry at Johns Hopkins Bayview, explains.
LYKETSOS: It’s the only study to date that tries to answer the question of whether people who take naproxen or celecoxib are more or less likely to get Alzheimer dementia than people who go on placebo, and the answer is if anything there’s a tendency for people on naproxen and celecoxib to do a little bit worse although that wasn’t really a major significant finding. :21Lyketsos says some benefit to taking these medications may appear as study participants are followed for the next several years, but right now, there appears to be no justification for taking naproxen or celecoxib with the hope of staving off Alzheimer’s disease. I’m Elizabeth Tracey reporting.